I agree with you also, and my post was not intended to suggest that I don't think it will be SOC or profitable or that a major player won't use. Just seems like we can't win here. Every positive gets flipped on its head. We get a good piece of news and almost always the "yeah, but..." crowd wins. until all the unkowns are known, it will be used as ammo against us longs. If they do announce the reimbursement amount, (and please god, I hope I am wrong, but I don't think that will come until June) they need to at least say they are in deep discussions with providers or nearing agreements with providers or at lease getting positive feedback from providers. I know we have a winner here. But for the life of me, I can't figure out why the institutions don't feel the same. I kind of thought we would be around 60 or 65% ownership by now. And I have a really hard time thinking I am smarter than they are.

I don't comment much over there, but I watch and listen. You all are super smart and knowledgeable, and I am just a little guy. I saw the PR and quickly skimmed looking for the reimbursement amount. When I didn't see it, I read it, thinking I missed it. I don't think anything nefarious is going on, but that is a huge missing piece that leaves the door open for negative thoughts and provides an opportunity for others to push it down. We all think it should be SOC, but at this point, it is not. We know it will be reimbursed, but we do not know how much other than CMS is pretty cheap, so who really knows. We know Frensius and Davita are the 2 major players, but we have no confirmation they will buy. Everything looks good, and the puzzle is coming together, but without knowing how much they can make and who has agreed to buy, it just leaves too much room for skepticism. I have been here for 7 years, and I am usually very calm and patient, but I am really frustrated today. I'm so tired of waiting for the next catalyst only to be let down. Sorry for the negatively - it's not usually my thing and I am holding. GL

FYI - Profound has been posting a few patient stories on their YouTube channel over the past couple weeks if interested to view.

My question is this: They say submission in May 2023, posted by June 2 and approved for 2025. I assume they mean June 2, 2023 not June 2, 2024?

From Raymond James: "CPT decisions from the May 2023 AMA meeting will be published on the AMA website on or before June 2, and will come into force January 2025."

A little confused with the Jefferies downgrade today. They lowered PROF from buy to hold and increased(?) price target from 5.50 to 10? Regardless, they are saying equal weight and hold - which is better than sell I guess. Probably won't help short term stock price.

https://biotuesdays.com/2023/03/15/rj-highlights-takeaways-from-kol-presentations-on-profounds-tulsa-pro/

Kinda thought they would maintain their 12 month outlook, but maybe note additional upside in the 24-month timeframe. I still firmly believe that getting a C code and insurance reimbursements fully complete is the primary driving factor for future usage and growth. But that won't be complete until Q1 2025 at the earliest it appears....and that's if the May meeting is positive. Still believe in this one long term.

Most of it. Got called away during Q&A. I don't disagree. I am just not all excited about 5% per month - primarily because I thought we would be dealing with a larger baseline at this point. I know it compounds, so the following isn't totally accurate, but a 5% increase to $1.3M is only about $39k more next quarter. I still believe in this, primarily due to management's prior track record with other companies, and I think this technology is superior. I will hold for now.....if it drops, I will probably add. May hedge by selling some covered calls to make a few extra bucks along the way.....and if they get called away, I'll bank it and be happy! I am disappointed, but not bearish by any means.

I guess I just think about where we started and where we are. Maybe I was foolish. But I kinda thought we would be farther along at this point. I totally get the COVID thing, but I still thought we'd be farther along. I could see us taking a hit. There is a lot of time between now and decent utilization. But if I think it will go down, which I do. Odds are it will go up.

They just said 35 installed. Dissapointing report though. 1.3M revenue is way lower than my expectations. We should be more than double last year IMO.

I really don't like playing this "when will it be approved game" cause everyone gets too ramped up about made-up timelines. The company didn't really guide anything specific, and didn't leave room for error. For instance, API supplier #1 provided FDA responses and changes, but that doesn't mean FDA accepted. With that said, the absolute best case scenario I saw was (assuming everything goes well), is possible approval in September. Request meeting mid March, FDA responds early April (14 days), Meeting early May (30 days), prepare and resubmit NDA class 2 early to Mid July (2 months rough estimate not guided), FDA approves early to mid September (60 days). This is best case and assumes no new on site inspection of existing manufacturer. If inspection is required, move from Q3 to Q4. As far as new CMO, figure summer 2024. My best guess and I am no pro. Good luck.

I really hope that either through Q4 results or 2023 guidance (preferably both), that management has some positive news. The last couple weren't exactly "to the moon" exciting. It's tough for me to listen live, but I am hoping to try and jump on. I just don't have high expectations, and I really hope they surprise me. GL

Not reading too much into today. Not a great day accross most small bios. And even though volume was up, it was still only around 60k so highly doubt any big player with inside info was flipping. I don't think tomorrow is going to be all that great (hope I am wrong), but I don't think today is an indicator of tomorrow's results.

Up 40% from when I exited my position. Congrats, guys. Still uncertain about long term, but I was definitely wrong about short-term and wanted to pop in and admit it. Congrats to those who are still holding!

Maybe the price we pay for very little retail presence is it doesn't pop as hard, but during market downtrends it doesn't sell off as hard either. I see about 5k volume right now

Held up very well this week in a volatile market. Let's see how the week ends.

I honestly don't remember details. I seem to recall that they kinda tempered expectations while maintaining a bullish outlook if that makes sense. Interested to see if they hit that 35 installs number yet.

I remember them saying they couldn't list every site for on their website some reason or another. Hopefully the next CC will add some clarity.

Let's hope Joe can get this across the finish line.

Looks like a new 13G filed for a new institutional investor who opened a new position with 1,180,425 shares all bought Q4. Probably added to run up. About half of outstanding shares are tied up with institutions with only about 20m outstanding as it is. Us little guys can fight over the remaining 10m shares. I agree with Hayfarmer and Chocolate that if retail figures this out, it could explode. I just hope that they do. Good luck
https://fintel.io/so/us/prof

On Twitter. Used mobile mri for first time.

This week we celebrate the 1st patient in Oklahoma to be treated using the #TULSAPRO and the 1st procedure performed in our Mobile MRI! Thank you to Perigon, Dr. Stratton, Surgical Hospital of Oklahoma and the entire team of urologists for bringing the TULSA-PRO to Oklahoma. pic.twitter.com/Q4n5YcBVJ7

— Profound Medical (@ProfoundMedical) February 2, 2023

May not hit $15 by the end of the month, but gotta give you props on the projected new high. You posted this on 1/13, and we hit a new high of $13.13 on 1/23. Well done. I will be standing by for any other projections. Good luck!

I could be completely wrong too....LOL. it is still there this morning.

Yeah, hard to tell. Probably more of a manipulative move to create a floor than an actual attempt to buy shares. I suppose it could have been an actual attempt hoping a tute was looking to reduce their position. Regardless, whatever they were doing, it was outside my pay grade.

I certainly hope you are both right!

I don't know that a heavy retail presence will ever occur. They don't really reach out to that type of investor. Take into account low volume and a PPS over $10, hard to assume retail will ever really pay attention......and that is fine with me. They have a solid % of shares held by institutions. Heavy retail works for traders, of which I am not. I think this PPS will be purely performance based. They get insurance figured out, more installations, more data. Etc, it will go up. Big delays or poor adoption of procedure or hang ups with insurance, it will go down.....as it should. Just my opinion.

That's a bold prediction chocolate man. Good luck!

Yeah, felt I had to say something. If I say something negative, it will undoubtedly go up. If I go positive, it will most likely go down.....LOL

Seems to have cooled off?

I figured it was you reestablishing your position.

Pushing towards 12 now Janey. You sniffing around here at all? Hard to buy into this run up.

Lately, if you want them, you gotta go get them. Very few sellers meeting the buyers bid. Buyers gotta meet the ask.

Volume all dried up....

300 shares at 12.98? Doesn't make much sense, but I am starting to wonder if there is some kind of pre-market communication via early trades going on here somehow? Every morning during this rise it seems someone buys some seemingly way overpriced pre-market shares. Then, the pps seems to rise to that point or thereabouts throughout the day. We will see if that trend continues - If it is a trend at all....I could have just taken an extra dose of crazy pills.

Certainly seems more buyers than sellers. Traded pretty thin this week, but as expected with holidays. My post wasn't meant to be negative - more bullish than anything. About a month ago I was considering a tax loss, now I am kicking myself that fear held me back... should have bought more. 2023 could be a strong year. Really needs to see revs bump up, but the stronger catalysts for this company comes down to 3 things in my opinion: 1. securing securing insurance reimbursements 2. wrapping up additional trials, 3. collecting of data from successful procedures. 3a. Additional write ups in medical journals. Good luck and I hope 2023 is a great year for you and yours.

So I had a little free time today and was searching up doctors comparing and explaining different prostate cancer available options, making sure to stay away from the ones speaking specifically in favor of a specific treatment. For instance, I didn't watch any doctors speaking specifically about Tulsa Pro. Based on what I was watching, one doctor spoke favorably about Tulsa but emphasized that there is only 1 documented FDA trial with published results. He said it could be great, but it's too early to tell. Another doctor was high on the procedure, but warned insurance doesn't usually cover much of the procedure. Basically, it's just early at this point based on my very limited research. Once more trials are complete, and reimbursements are finalized, this could really take off if it can find a way to explicitly separate itself from HIFU. It appears significantly better than HIFU, but the tech is similar and HIFU is widely used currently.

They got some pretty cool stuff on Twitter. PROF acts more like a big company than a small one with their PR. Small and start up bios would be PRing all of this stuff. They do twitter posts.

#ICYMI No MRI time? No problem. #Profound is excited to announce that the TULSA-PRO is going mobile and will be available in a mobile MRI!#scienceandtechnology #urology #radiology #tulsapro #tulsaprocedure pic.twitter.com/nAiLzqdmxl

— Profound Medical (@ProfoundMedical) December 17, 2022

Can't take too much credit. Took a peak over at the twits and found it. Crazy board, but sometimes useful info can be found. PROF is very scarcely commented on over there too.

https://biotuesdays.com/2022/12/21/profound-medical-ceo-adds-to-holdings-again/